Cite
Metabolic Syndrome in people treated with Antipsychotics (RISKMet): A multimethod study protocol investigating genetic, behavioural, and environmental risk factors.
MLA
de Girolamo, Giovanni, et al. “Metabolic Syndrome in People Treated with Antipsychotics (RISKMet): A Multimethod Study Protocol Investigating Genetic, Behavioural, and Environmental Risk Factors.” PLoS ONE, vol. 19, no. 5, May 2024, pp. 1–19. EBSCOhost, https://doi.org/10.1371/journal.pone.0298161.
APA
de Girolamo, G., La Cascia, C., Macchia, P. E., Nobile, M., Calza, S., Camillo, L., Mauri, M., Pozzi, M., Tripoli, G., Vetrani, C., Caselani, E., & Magno, M. (2024). Metabolic Syndrome in people treated with Antipsychotics (RISKMet): A multimethod study protocol investigating genetic, behavioural, and environmental risk factors. PLoS ONE, 19(5), 1–19. https://doi.org/10.1371/journal.pone.0298161
Chicago
de Girolamo, Giovanni, Caterina La Cascia, Paolo Emidio Macchia, Maria Nobile, Stefano Calza, Laura Camillo, Maddalena Mauri, et al. 2024. “Metabolic Syndrome in People Treated with Antipsychotics (RISKMet): A Multimethod Study Protocol Investigating Genetic, Behavioural, and Environmental Risk Factors.” PLoS ONE 19 (5): 1–19. doi:10.1371/journal.pone.0298161.